Hans Hull

CIK 1614876 · Chief Business Officer · last filed 2025-01-27

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$288.7K

Companies

2

Total Filings

26

Lifetime Open-Market Net

-$3.11M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PLRX Chief Business Officer 255,529 $1.13 $288.7K -$1.82M 18 2025-01-27
Adverum Biotechnologies, Inc. (AAVL) Delisted Chief Executive Officer 137,210 -$1.29M 8 2015-08-25

Recent Filings · Page 2 of 3

26 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-03-31 PLRX Grant (A) +17,578 $0 EDGAR
2023-01-27 PLRX Grant (A) +54,000 $0 EDGAR
2022-12-21 PLRX Mixed +8,830 -$167.1K EDGAR
2022-02-02 PLRX Grant (A) $0 EDGAR
2021-05-28 PLRX Exer (M) +4,500 $9.4K EDGAR
2021-01-26 PLRX Grant (A) $0 EDGAR
2021-01-04 PLRX Exer (M) +3,500 $7.3K EDGAR
2020-06-09 PLRX Mixed +8,900 $0 EDGAR
2015-08-25 Adverum Biotechnologies, Inc. (AAVL) Delisted Grant (A) +117,590 $0 EDGAR
2015-06-16 Adverum Biotechnologies, Inc. (AAVL) Delisted Exer (M) +8,300 $1.6K EDGAR
Showing 1120 of 26
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.